Showing results (1-10 of 347) with videos related to
Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer-A Perspective on Future Trial DesignsSteffen Ventz, Lorenzo Trippa, Jonathan D SchoenfeldNature Communications|February 6, 2021
The effects of releasing early results from ongoing clinical trialsSteffen Ventz, Sergio Bacallado, Rifaquat Rahman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2017
Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast CancerSteffen Ventz, Brian M Alexander, Giovanni Parmigiani, et al.JCO Precision Oncology|January 20, 2022
Meta-Analysis of PD-L1 Expression As a Predictor of Survival After Checkpoint BlockadeAndrea Arfè, Geoffrey Fell, Brian Alexander, et al.Neuro-Oncology|January 9, 2015
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trialsLorenzo Trippa, Patrick Y Wen, Giovanni Parmigiani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World DataSteffen Ventz, Albert Lai, Timothy F Cloughesy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2019
Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and ImplicationsRifaquat Rahman, Geoffrey Fell, Steffen Ventz, et al.Neuro-Oncology|June 9, 2021
The use of external control data for predictions and futility interim analyses in clinical trialsSteffen Ventz, Leah Comment, Bill Louv, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical TrialsRifaquat Rahman, Steffen Ventz, Robert Redd, et al.JCO Precision Oncology|February 27, 2023
Validation of Predictive Analyses for Interim Decisions in Clinical TrialsAlejandra Avalos-Pacheco, Steffen Ventz, Andrea Arfè, et al.Pageof 35